mining plasma proteome cancer biomarkers 
systematic searches plasma proteins biological indicators biomarkers cancer underway difficulties caused complexity biological fluid proteomes tissue proteomes contribute proteins plasma extensive heterogeneity among diseases subjects levels sample procurement gradually overcome achieved rigorous experimental design depth quantitative studies expected outcome development panels biomarkers will allow early detection cancer prediction probable response therapy achieving objectives requires high quality specimens well matched controls reagent resources efficient process confirm discoveries independent validation studies 
